Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
HomeScreenerChatCompanies
Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
Companies/908 Devices Inc.
Company profile

908 Devices Inc.

NASDAQ: MASS · Healthcare · Medical - Specialties
PublicHQ Burlington, MA · MiddlesexCIK 0001555279Reports USD
#414 of 1,394 Healthcare companies by revenue34th-percentile growth
EA Score
59C
FH 71DQ 46GM 53SS 56
v0.1 · 65/100 weight · provisional
↑ net margin, return on assets · ↓ Piotroski F, listing tenure
Methodology →
Revenue TTM
$57.8M
Rev growth YoY (TTM)
+2.2%
Net income (FY)
$19.5M
Employees
172
Market cap
$328.6M
OverviewFinancialsSegmentsFilingsESGPeople & Places

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$56.2M$56.2M2025
Net income$19.5M$19.5M2025
Operating income-$39.4M-$39.4M2025
Total assets$190.1M$190.1M2025
Liabilities$46.4M$46.4M2025
Equity$143.7M$143.7M2025

Revenue trend

FY2021 – FY2025 · USD
$26.9M
FY21
$42.2M
FY21
$46.9M
FY22
$50.2M
FY23
$59.6M
FY24
$56.2M
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Device Sales58%
Recurring31%
Product and service revenue11%
Contract0%
By geography
UNITED STATES73%
Europe, Middle East and Africa19%
Asia Pacific5%
Americas other3%
The read

908 Devices Inc. booked $56.2M in FY2025 revenue, contracting 5.8% year over year — slower than 66% of Healthcare companies we track, at a 34.7% net margin.

Peers · Healthcare
CytoDyn Inc.30DLyell Immunopharma, Inc.32DAkebia Therapeutics, Inc.66BGreenwich LifeSciences, Inc.——
Neighbors
Middlesex →
GE Vernova Inc.$38.1B63CThermo Fisher Scientific Inc.$44.6B86AAnalog Devices, Inc.$11.0B87AThe TJX Companies, Inc.$60.4B85ABoston Scientific Corporation$20.1B88AAlnylam Pharmaceuticals, Inc.$3.7B79B+
Key facts
CEOKevin J. Knopp
SectorHealthcare
IndustryMedical - Specialties
HeadquartersBurlington, MA
ExchangeNASDAQ: MASS
Employees172
IPO date2020-12-18
Latest filings
8-K2026-07-088-K2026-06-1210-Q2026-05-068-K2026-05-06DEF 14A2026-04-2910-K2026-03-098-K2026-03-038-K2026-01-20
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.
HomeScreenerChatCompanies